Description

What is RETAMED (Triple Receptor Agonist)?

RETAMED acts on three receptors at once, which is why it produces more weight loss than anything else in this class. It cuts appetite and raises how much you burn at the same time.

RETAMED acts on three receptors rather than one. GLP-1 and GIP both reduce appetite and improve blood sugar handling, which is what the single and dual agonists do. The third, the glucagon receptor, is what sets a triple agonist apart: activating it raises energy expenditure, so you burn more while appetite is already reduced.

RETAMED benefits

• The strongest weight loss of anything in this class
• Raises energy expenditure through the glucagon arm rather than only suppressing appetite
• One subcutaneous injection a week
• Improves blood sugar handling alongside the weight loss
• Not androgenic, so nothing is suppressed and no post-cycle therapy applies

RETAMED dosage

Starting dose

2mg once weekly

Common range

4 to 8mg once weekly

Titration

Increase every 4 weeks, not sooner

Route

Subcutaneous, once weekly

Vial contains

10mg

Half-life

Around 6 days

Start at 2mg and move up in steps of a few weeks. The glucagon arm makes this more potent than a single or dual agonist, so the titration matters more here rather than less.

Reconstitute with bacteriostatic water. The reconstitution guide covers the method and the dosage calculator works out the concentration.

Package content

Vial

1 vial of lyophilised powder

RETAMED per vial

10mg

Form

Lyophilised powder for reconstitution

Diluent

Bacteriostatic water, sold separately

Half-life

Around 6 days

Brand

Deus Medical

At 4mg weekly one vial covers around two and a half weeks.

Store below 30°C. Protect from light. Do not freeze. Keep out of reach of children.